The Discounted Cash Flow (DCF) valuation of PW Medtech Group Ltd (1358.HK) is 2.33 HKD. With the latest stock price at 1.46 HKD, the upside of PW Medtech Group Ltd based on DCF is 59.6%.
Based on the latest price of 1.46 HKD and our DCF valuation, PW Medtech Group Ltd (1358.HK) is a buy. buying 1358.HK stocks now will result in a potential gain of 59.6%.
| Range | Selected | |
| WACC / Discount Rate | 10.0% - 13.5% | 11.8% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 2.16 - 2.58 | 2.33 |
| Upside | 48.0% - 76.9% | 59.6% |